Ferdinand Irizarry / JMH Consulting Group, Inc.
BD / Intermediary Actor · Cyberlux Equity Recipient · Lobbying Principal
Ferdinand Irizarry is the individual named alongside JMH Consulting Group, Inc. in Cyberlux's OTC shareholder record. The share issuance — 10,000,000 unrestricted common shares on March 26, 2024, under a consulting agreement — is documented in Cyberlux's annual filings for fiscal years 2024 and 2025. The shares were issued as unrestricted, distinguishing them from the restricted shares issued to other consultants and employees during the same period.
What this profile says up front
The firm that lobbied for the contract, represented a claimant against it, and received equity in the issuer
Ferdinand Irizarry is the individual named alongside JMH Consulting Group, Inc. in Cyberlux's OTC shareholder record. The share issuance — 10,000,000 unrestricted common shares on March 26, 2024, under a consulting agreement — is documented in Cyberlux's annual filings for fiscal years 2024 and 2025. The shares were issued as unrestricted, distinguishing them from the restricted shares issued to other consultants and employees during the same period.
JMH Group's role in the Cyberlux ecosystem is documented across three distinct channels: lobbying disclosure filings, the Fairwinds Technologies commission claim in the interpleader, and the OTC equity compensation record. Each channel involves a different financial relationship with a different party to the same underlying transaction. The overlap between them has not been addressed in any public filing.
The findings below are drawn from OTC annual filings, LD-2 lobbying disclosures, and the interpleader record. Irizarry appears across nine documents in the corpus by name; JMH Group's activities span a larger document set.
The numbers that frame the profile
What the record establishes
Equity compensation: 10M unrestricted shares, March 2024
Cyberlux Corporation's OTC annual filings for fiscal years 2024 and 2025 record the issuance of 10,000,000 common shares to JMH Consulting Group, Inc. / Ferdinand Irizarry on March 26, 2024, under a consulting agreement. The shares are designated as unrestricted — a category distinct from the restricted shares issued to other consultants and employees in the same filing period. The issuance date is approximately three months after the Stop Work Order (December 22, 2023) and after the contract was heading toward the Modification 4 termination settlement.
JMH Group's Q4 2023 lobbying: Cyberlux client, DSCA and congressional targets
JMH Group's LD-2 lobbying disclosure filings document outreach in Q4 2023 to Armed Services, Foreign Relations, and Appropriations committee members and staff, and to DSCA — the Defense Security Cooperation Agency, which administers Foreign Military Financing. The subject matter included drone capabilities, the Replicator Program, and Ukraine appropriations. This lobbying occurred in the same quarter the Stop Work Order was issued. JMH's client for this engagement was Cyberlux.
JMH Group simultaneously registered as Fairwinds Technologies' lobbyist
JMH Group is simultaneously registered as the lobbyist for Fairwinds Technologies LLC — the 8% commission claimant in the interpleader. The firm conducting congressional and agency outreach for Cyberlux also represents a financial claimant against what that outreach was for. The Fairwinds commission claim and the JMH lobbying activity are documented in the same interpleader exhibit set.
The three-way financial overlap and disclosure questions
The combination of JMH's three documented roles — Cyberlux lobbyist, Fairwinds lobbyist/representative, and Cyberlux equity recipient — creates a structural financial interest that intersects with each engagement. Whether this overlap was disclosed to the congressional staff and agency officials contacted in Q4 2023, to the Fairwinds Technologies client, or in JMH's lobbying registrations does not appear in any public filing.
Unrestricted vs. restricted share distinction
The OTC filing record shows other Cyberlux consultants and employees receiving restricted shares during the same period. Irizarry/JMH received unrestricted shares — a form of compensation that carries no holding period restriction and can be sold immediately upon issuance. The value of 10 million unrestricted CYBL shares at issuance, and any subsequent disposition of those shares, is not addressed in any public filing reviewed for this brief.